Clinical Trials Logo

Clinical Trial Summary

If the classification between hereditary and acquired neuropathy is often easy, there is no completely specific marker allowing the distinction between the two etiologies. Clinical experience suggests that hereditary neuropathies have less impact on balance and gait than the acquired neuropathies at equivalent level of impairment, but this has never been clearly demonstrated.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04154540
Study type Interventional
Source University Hospital, Lille
Contact Céline TARD, MD
Phone 0320445765
Email celine.tard@chru-lille.fr
Status Recruiting
Phase N/A
Start date May 19, 2021
Completion date December 2023

See also
  Status Clinical Trial Phase
Completed NCT03268161 - Prevalence of Genetic Mutations in Patients With Neuropathy Associated With Anti-Myelin-associated Glycoprotein (MAG) Antibodies N/A